Rural 340B Access Act of 2024
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Rural 340B Access Act of 2024 is a House bill introduced in the 118th Congress aimed at addressing issues related to the 340B Drug Pricing Program, specifically focusing on improving access for rural healthcare providers. The bill was referred to the Subcommittee on Health but did not advance further and ultimately failed or expired. No official summary or full text is available to provide detailed provisions or mechanisms of the bill.
This bill sought to enhance rural healthcare providers' access to the 340B drug pricing program but did not progress beyond initial committee referral and expired without enactment.
- The bill is titled the Rural 340B Access Act of 2024 and was introduced in the House of Representatives during the 118th Congress.
- It focuses on the health policy area, specifically targeting the 340B Drug Pricing Program and rural healthcare access.
- The latest recorded action was referral to the Subcommittee on Health on May 3, 2024, with no further legislative movement before expiration.
['Rural healthcare providers who participate or seek to participate in the 340B Drug Pricing Program', 'Patients in rural areas who may gain improved access to discounted prescription drugs', 'Healthcare organizations serving rural communities']
['Lack of available full bill text and official summary limits understanding of specific provisions and implementation details', 'Potential cost implications for federal drug pricing programs or healthcare budgets are unknown', 'Oversight and enforcement mechanisms are not described, raising questions about accountability', "The bill's failure to advance suggests possible legislative or policy challenges"]
The bill was introduced in the House during the 118th Congress and referred to the Subcommittee on Health but did not advance further. It addresses the 340B Drug Pricing Program, a federal program designed to help healthcare providers serving vulnerable populations access discounted outpatient drugs. The focus on rural access reflects ongoing policy discussions about healthcare disparities in rural areas.
Hidden impact flags detected: 1
GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['If enacted, the bill could influence drug pricing negotiations and access for rural healthcare providers beyond direct 340B program participants.', 'Potential shifts in healthcare delivery patterns in rural areas due to improved drug access.', 'Possible budgetary impacts on federal healthcare programs depending on how drug discounts are structured.']
The absence of an official summary and full bill text limits transparency and public understanding of the bill's provisions and potential effects. Tracking the bill's referral to the Subcommittee on Health without further action highlights the importance of monitoring legislative progress and ensuring accessible documentation for public oversight.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.